NEW YORK (GenomeWeb News) – Molecular diagnostics company Rheonix today announced a joint development agreement with Life Technologies aimed at a molecular testing platform for the applied markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.